EPIDEMIOLOGICAL DATA ON THE DETECTION OF IMMUNOGLOBULINS OF CLASS IGM, IGG TO SARS-COV-2 AMONG POPULATION OF POLTAVA REGION.

Autor:	Marchenko AV; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE., Ananieva MM; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE., Faustova MO; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE., Loban' GA; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE., Lytovchenko IY; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE., Nikolishyn IA; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE., Ilenko-Lobach NV; UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY, POLTAVA, UKRAINE.
Jazyk:	angličtina
Zdroj:	Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2021; Vol. 74 (5), pp. 1134-1136.
Abstrakt:	Objective: The aim: Of this study was to analyze epidemiological data on the detection of immunoglobulins of class M and G (IgM, IgG) to SARS-CoV-2 among urban and rural population of Poltava region. Patients and Methods: Materials and methods: We have analyzed the research results of 2841 patients to determine IgM and IgG levels to SARS-CoV-2. The study included the results of patients in Poltava and nearby villages of Poltava region, obtained during July - December 2020. Results: Results: Thus, 84% of patients applied for detection of IgM in the serum of patients with the pathogen COVID-2019. We have found only 135 positive results for the detection of IgM to SARS-CoV-2, which was 5.7% of the total number of people who underwent this study from July to December 2020. Moreover, women received a positive result more often than men. The IP samples for the detection of IgM to SARS-CoV-2 in the serum of patients averaged 2.5 ± 1.04. It was found that patients went to the laboratory to detect IgG to SARS-CoV-2 with the vast majority among them were residents of Poltava. However, in this case the share of positive results was 47.7%, among which the female population outnumbered the male. Conclusion: Conclusions: The frequency of detection of positive results on IgM to SARS-CoV-2 is about 6%. The share of positive results on IgG to SARS-CoV-2 was 47.7%, among them 76.2% were women. The frequency of detection of IgM and IgG to SARS-CoV-2 during October-December 2020 significantly exceeds the indices in July-September of the same year.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu